ZA952242B - Recombinant viruses their preparation and their use in gene therapy - Google Patents

Recombinant viruses their preparation and their use in gene therapy

Info

Publication number
ZA952242B
ZA952242B ZA952242A ZA952242A ZA952242B ZA 952242 B ZA952242 B ZA 952242B ZA 952242 A ZA952242 A ZA 952242A ZA 952242 A ZA952242 A ZA 952242A ZA 952242 B ZA952242 B ZA 952242B
Authority
ZA
South Africa
Prior art keywords
preparation
gene therapy
recombinant viruses
viruses
recombinant
Prior art date
Application number
ZA952242A
Other languages
English (en)
Inventor
Pascal Barneoud
Pia Delaere
Michel Perricaudet
Laurent Pradier
Emmanuelle Vigne
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA952242B publication Critical patent/ZA952242B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]
    • C07K14/501—Fibroblast growth factors [FGF] acidic FGF [aFGF]
ZA952242A 1994-03-18 1995-03-17 Recombinant viruses their preparation and their use in gene therapy ZA952242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9403190A FR2717495B1 (fr) 1994-03-18 1994-03-18 Virus recombinants, préparation et utilisation en thérapie génique.

Publications (1)

Publication Number Publication Date
ZA952242B true ZA952242B (en) 1996-01-09

Family

ID=9461189

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA952242A ZA952242B (en) 1994-03-18 1995-03-17 Recombinant viruses their preparation and their use in gene therapy

Country Status (8)

Country Link
EP (1) EP0750675A1 (fr)
JP (1) JPH09510357A (fr)
AU (1) AU1896195A (fr)
CA (1) CA2184409A1 (fr)
FR (1) FR2717495B1 (fr)
IL (1) IL112993A (fr)
WO (1) WO1995025803A1 (fr)
ZA (1) ZA952242B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2188575A1 (fr) 1995-02-28 1996-09-06 H. Kirk Hammond Therapie angiogenique par transfert de genes
US5792453A (en) * 1995-02-28 1998-08-11 The Regents Of The University Of California Gene transfer-mediated angiogenesis therapy
FR2792531B1 (fr) * 1999-04-26 2003-01-31 Aventis Pharma Sa Utilisation d'adenovirus recombinant defectif comprenant un acide nucleique codant pour un facteur angiogenique pour le traitement de l'hypertension arterielle pulmonaire
KR20020001846A (ko) * 1999-04-26 2002-01-09 추후제출 폐순환승압을 치료하기 위한 맥관형성 인자를 암호화 하는핵산을 포함하는 재조합 결손 아데노바이러스의 용도
CA2430112C (fr) 2000-11-27 2010-07-27 Dnavec Research Inc. Vecteur de paramyxovirus encodant le gene de l'angiogenese et son utilisation
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
WO2009128474A1 (fr) 2008-04-16 2009-10-22 財団法人化学及血清療法研究所 Procédé de production d'une préparation de feuille bioabsorbable sur laquelle de la thrombine a été immobilisée

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2814529B2 (ja) * 1989-03-16 1998-10-22 味の素株式会社 虚血性脳障害治療薬
NZ241021A (en) * 1990-12-18 1993-12-23 Amgen Inc Analogues of acidic fibroblast growth factor and pharmaceutical
AU3129793A (en) * 1991-11-08 1993-06-07 General Hospital Corporation, The Methods for the treatment of neuronal damage associated with ischemia, hypoxia or neurodegeneration
FR2688514A1 (fr) * 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
CA2145535C (fr) * 1992-09-25 2007-07-17 Axel Kahn Vecteurs adenoviraux pour le transfert de genes etrangers dans des cellules du systeme nerveux central, notamment dans le cerveau
FR2704234B1 (fr) * 1993-04-22 1995-07-21 Centre Nat Rech Scient Virus recombinants, preparation et utilisation en therapie genique.

Also Published As

Publication number Publication date
EP0750675A1 (fr) 1997-01-02
FR2717495A1 (fr) 1995-09-22
WO1995025803A1 (fr) 1995-09-28
CA2184409A1 (fr) 1995-09-28
AU1896195A (en) 1995-10-09
FR2717495B1 (fr) 1996-04-12
JPH09510357A (ja) 1997-10-21
IL112993A (en) 2006-09-05
IL112993A0 (en) 1995-06-29

Similar Documents

Publication Publication Date Title
IL111681A0 (en) Recombinant viruses and their use in gene therapy
ZA951803B (en) Recombinant viruses their preparation and their therapeutic use
ZA952563B (en) Recombinant viruses their preparation and their use in gene therapy
IL115584A0 (en) Viral vectors and their use in gene therapy
AU4032893A (en) Human papilloma virus genes and their use in gene therapy
ZA945012B (en) Viral vectors and their use in gene therapy
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
HUP9801216A3 (en) Dna molecules, preparation thereof and use thereof in gene therapy
HU9503751D0 (en) Antisense oligonucleotides and therapeutic use thereof in human immunodeficiency virus infection
SG54275A1 (en) Dna coding for decarbamylase improved in thermostability and use thereof
ZA949103B (en) Recombinant viruses and their use in gene therapy
ZA956849B (en) Use of a defective recombinant adenovirus in gene therapy
IL117466A0 (en) Recombinant viruses expressing lecithin-cholesterol acryltransferase and their use in gene therapy
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
IL112075A0 (en) Recombinant human thymopoietin proteins, their preparation and their medicinal use
ZA952242B (en) Recombinant viruses their preparation and their use in gene therapy
ZA964563B (en) Isoindole derivatives their preparation and their application in therapy
ZA952244B (en) Recombinant viruses their preparation and their use in gene therapy
IL128902A0 (en) N-(2-benzothiazolyl)-1-piperidineethanamine derivatives their preparation and their use in therapy
ZA959904B (en) Iminooxymethyleneanilides thei preparation and their use
FR2725213B1 (fr) Vecteurs viraux et utilisation en therapie genique
IL113725A0 (en) Preparing recombinant aprotini and its variants
ZA952286B (en) Recombinant viruses their preparation and their use in gene therapy
ZA952243B (en) Recombinant viruses their preparation and their use in gene therapy
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use